A citation-based method for searching scientific literature

Renju Kuriakose, A Jon Stoessl. Prog Brain Res 2010
Times Cited: 15







List of co-cited articles
82 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Raúl de la Fuente-Fernández, Vesna Sossi, Zhigao Huang, Sarah Furtado, Jian-Qiang Lu, Donald B Calne, Thomas J Ruth, A Jon Stoessl. Brain 2004
291
26

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H Bernheimer, W Birkmayer, O Hornykiewicz, K Jellinger, F Seitelberger. J Neurol Sci 1973
20

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
Daniella Rylander, Martin Parent, Sean S O'Sullivan, Sandra Dovero, Andrew J Lees, Erwan Bezard, Laurent Descarries, M Angela Cenci. Ann Neurol 2010
171
20

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
20

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
20

Neuroimaging of dyskinesia.
D J Brooks, P Piccini, N Turjanski, M Samuel. Ann Neurol 2000
65
20


Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Claire L Tomlinson, Rebecca Stowe, Smitaa Patel, Caroline Rick, Richard Gray, Carl E Clarke. Mov Disord 2010
20

Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
Jin Yong Hong, Jungsu S Oh, Injoo Lee, Mun Kyung Sunwoo, Jee Hyun Ham, Ji E Lee, Young H Sohn, Jae Seung Kim, Phil Hyu Lee. Neurology 2014
59
20

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
20

Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
Bai-Yun Zeng, Mahmoud M Iravani, Michael J Jackson, Sarah Rose, André Parent, Peter Jenner. Neurobiol Dis 2010
51
13


Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
M Lundblad, M Andersson, C Winkler, D Kirik, N Wierup, M Angela Cenci. Eur J Neurosci 2002
492
13

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
Manolo Carta, Thomas Carlsson, Deniz Kirik, Anders Björklund. Brain 2007
449
13


Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
Ana Muñoz, Qin Li, Fabrizio Gardoni, Elena Marcello, Chuan Qin, Thomas Carlsson, Deniz Kirik, Monica Di Luca, Anders Björklund, Erwan Bezard,[...]. Brain 2008
184
13


Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Daniel B Putterman, Adam C Munhall, Laura B Kozell, John K Belknap, Steven W Johnson. J Pharmacol Exp Ther 2007
56
13

Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism.
Xiaoqun Zhang, Per E Andren, Paul Greengard, Per Svenningsson. Proc Natl Acad Sci U S A 2008
82
13

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.
C Marin, E Aguilar, M C Rodríguez-Oroz, G D Bartoszyk, J A Obeso. Psychopharmacology (Berl) 2009
41
13


Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats.
H Tanaka, K Kannari, T Maeda, M Tomiyama, T Suda, M Matsunaga. Neuroreport 1999
213
13

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
M Angela Cenci, Martin Lundblad. J Neurochem 2006
149
13


Role of hyperactive cerebellum and motor cortex in Parkinson's disease.
Hong Yu, Dagmar Sternad, Daniel M Corcos, David E Vaillancourt. Neuroimage 2007
259
13

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
13

Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease.
S J Palmer, J Li, Z J Wang, M J McKeown. Neuroscience 2010
67
13

Imaging biomarkers in Parkinson's disease.
David J Brooks, Nicola Pavese. Prog Neurobiol 2011
97
13

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
13

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
Paolo Gubellini, Barbara Picconi, Monica Bari, Natalia Battista, Paolo Calabresi, Diego Centonze, Giorgio Bernardi, Alessandro Finazzi-Agrò, Mauro Maccarrone. J Neurosci 2002
215
13

Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Céline Guigoni, Evelyne Doudnikoff, Qin Li, Bertrand Bloch, Erwan Bezard. Neurobiol Dis 2007
100
13

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
150
13


Molecular mechanisms of L-DOPA-induced dyskinesia.
Peter Jenner. Nat Rev Neurosci 2008
342
13

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
O Rascol, U Sabatini, C Brefel, N Fabre, S Rai, J M Senard, P Celsis, G Viallard, J L Montastruc, F Chollet. Brain 1998
124
13

Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.
K Elisabet Ohlin, Irene Sebastianutto, Chris E Adkins, Cornelia Lundblad, Paul R Lockman, M Angela Cenci. Neuroimage 2012
54
13



Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Antonio Cerasa, Pierfrancesco Pugliese, Demetrio Messina, Maurizio Morelli, Maria Cecilia Gioia, Maria Salsone, Fabiana Novellino, Giuseppe Nicoletti, Gennarina Arabia, Aldo Quattrone. Mov Disord 2012
54
13

Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology.
Anthony C Vernon, William R Crum, Jason P Lerch, Winfred Chege, Sridhar Natesan, Michel Modo, Jonathan D Cooper, Steven C R Williams, Shitij Kapur. Biol Psychiatry 2014
64
13


Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.
Paolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri, Nicola Tambasco, Barbara Picconi. Lancet Neurol 2010
242
13

Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
Antonio Cerasa, Demetrio Messina, Pierfrancesco Pugliese, Maurizio Morelli, Pierluigi Lanza, Maria Salsone, Fabiana Novellino, Giuseppe Nicoletti, Gennarina Arabia, Aldo Quattrone. Mov Disord 2011
49
13

Treatment of parkinsonism with levodopa.
M D Yahr, R C Duvoisin, M J Schear, R E Barrett, M M Hoehn. Arch Neurol 1969
553
13



Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Antonio Cerasa, Maria Salsone, Maurizio Morelli, Pierfrancesco Pugliese, Gennarina Arabia, Cecilia M Gioia, Fabiana Novellino, Aldo Quattrone. Parkinsonism Relat Disord 2013
20
13

Levodopa-induced dyskinesia in Parkinson's disease.
J M Brotchie, J Lee, K Venderova. J Neural Transm (Vienna) 2005
69
13

Levodopa in the treatment of Parkinson's disease.
A H V Schapira, M Emre, P Jenner, W Poewe. Eur J Neurol 2009
103
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.